carfentanil: Clinical Trials

5 trials of carfentanil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 3 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Active not recruiting 1
Not applicable1Not yet recruiting 1
Phase 21Terminated 1

Follow carfentanil: new trials by email Literature Review of carfentanil trials Research Report on carfentanil

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Opioidergic and Noradrenergic Systems in Central Parkisonian Pain
PET-MRI exam with administration of [11C]Carfentanil, PET-MRI exam with administration of [11C]Yohimbine - Parkinson Disease
Not applicableNot yet recruitingHospices Civils de Lyon552025-10-012025-08-17
Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing
CVL-354, [11C]-LY2795050, [11C]-carfentanil - Opioid Use Disorder
Phase 1CompletedCerevel Therapeutics, LLC192023-03-022025-07-14
Multi-System Analysis of Opioid Receptor Binding
Carfentanil, C-11, Naloxone, Loperamide Hydrochloride - Healthy, Opioid Use Disorder
Phase 1Active not recruitingUniversity of Pennsylvania252022-09-202026-03-30
Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain
Deep brain stimulation, Cervel Neurotech, Multi-coil TMS, 11C-Carfentanil - Neuralgia
Phase 2TerminatedUniversity of Aarhus32014-04-012021-09-14
Effects of Smoking on Opioid Receptor Binding: A PET Study
Nicotine, Carfentanil - Substance-related Discorder
Phase 1CompletedNational Institute on Drug Abuse (NIDA)262008-01-172018-04-05

Conditions studied

Opioid-Related Disorders (2)  ·  Neuralgia (1)  ·  Pain (1)  ·  Parkinson Disease (1)  ·  Smoking (1)

Sponsors

Cerevel Therapeutics, LLC (1)  ·  Hospices Civils de Lyon (1)  ·  National Institute on Drug Abuse (NIDA) (1)  ·  University of Aarhus (1)  ·  University of Pennsylvania (1)

Countries

United States (3)  ·  Denmark (1)  ·  France (1)

Top investigators

Stephen J Heishman, Ph.D. (1)

Results publications

PMID 40341091

NIH funding

4UH3DA052166-02 (1)